- Home
- GIB vs ELAN Comparison
GIB vs ELAN Comparison
Compare GIB & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GIB | ELAN |
|---|---|---|
| Founded | 1976 | 1954 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 12.4B |
| IPO Year | 1999 | 2018 |
Fundamental Metrics
Financial Performance| Metric | GIB | ELAN |
|---|---|---|
| Price | $66.56 | $24.99 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $112.00 | $27.89 |
| AVG Volume (30 Days) | 393.1K | ★ 3.8M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | $8.33 | $8.21 |
| Revenue Next Year | $2.96 | $5.31 |
| P/E Ratio | ★ $13.59 | $225.27 |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $59.63 | $13.39 |
| 52 Week High | $103.04 | $27.72 |
Technical Indicators
Market Signals| Indicator | GIB | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 52.10 | 51.39 |
| Support Level | $60.78 | $23.56 |
| Resistance Level | $69.13 | $25.35 |
| Average True Range (ATR) | 1.70 | 0.88 |
| MACD | -0.06 | -0.09 |
| Stochastic Oscillator | 66.37 | 44.99 |
Price Performance
Historical ComparisonAbout GIB CGI Inc.
CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.